|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine
Hyunwoo Lee, Yoon Ah Cho, Deok Geun Kim, Eun Yoon Cho
Cancer Res Treat.
2024;56(1):149-161. Published online August 11, 2023 DOI:
https://doi.org/10.4143/crt.2023.800
Web of Science 4
Crossref 4
Short-term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in
BRCA
Mutation Carriers: A Nationwide Study in South Korea
Hye Yeon Kim, Jisoo Park, Seok Joo Moon, Sohyeon Jeong, Jin Hwa Hong, Jae Kwan Lee, Geum Joon Cho, Hyun-Woong Cho
Cancer Res Treat.
2024;56(1):143-148. Published online August 16, 2023 DOI:
https://doi.org/10.4143/crt.2023.653
Web of Science 1
Crossref 1
Gynecologic cancer
Effect of
BRCA1/2
Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.
2023;55(1):245-257. Published online July 19, 2022 DOI:
https://doi.org/10.4143/crt.2022.232
General
Reclassification of Five
BRCA1
/
2
Variants with Unknown Significance Using Complex Functional Study
Anikó Bozsik, János Papp, Vince Kornél Grolmusz, Attila Patócs, Edit Oláh, Henriett Butz
Cancer Res Treat.
2022;54(4):970-984. Published online February 8, 2022 DOI:
https://doi.org/10.4143/crt.2021.1078
Web of Science 2
Crossref 2
Breast cancer
Clinicopathological Characterization of Double Heterozygosity for
BRCA1
and
BRCA2
Variants in Korean Breast Cancer Patients
Yoon Ju Bang, Won Kyung Kwon, Seok Jin Nam, Seok Won Kim, Byung-Joo Chae, Se Kyung Lee, Jai Min Ryu, Jong-Won Kim, Jonghan Yu, Jeong Eon Lee
Cancer Res Treat.
2022;54(3):827-833. Published online October 13, 2021 DOI:
https://doi.org/10.4143/crt.2021.791
Web of Science 3
Crossref 3
Clinical and Genetic Characteristics of
BRCA1/2
Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review
Byung Su Kwon, Jung Mi Byun, Hyun Joo Lee, Dae Hoon Jeong, Tae Hwa Lee, Kyung-Hwa Shin, Dong Soo Suh, Ki Hyung Kim
Cancer Res Treat.
2019;51(3):941-950. Published online October 8, 2018 DOI:
https://doi.org/10.4143/crt.2018.312
Web of Science 11
Crossref 11
Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2019;51(1):280-288. Published online May 4, 2018 DOI:
https://doi.org/10.4143/crt.2018.079
Web of Science 12
Crossref 10
Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
BRCA1
and
BRCA2
Sang Mee Hwang, Ki Chan Lee, Min Seob Lee, Kyoung Un Park
Cancer Res Treat.
2018;50(1):255-264. Published online April 7, 2017 DOI:
https://doi.org/10.4143/crt.2017.062
Web of Science 3
Crossref 4
Identification of a Novel
BRCA1
Pathogenic Mutation in Korean Patients Following Reclassification of
BRCA1
and
BRCA2
Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls
Ji Soo Park, Eun Ji Nam, Hyung Seok Park, Jung Woo Han, Jung-Yun Lee, Jieun Kim, Tae Il Kim, Seung-Tae Lee
Cancer Res Treat.
2017;49(4):1012-1021. Published online January 17, 2017 DOI:
https://doi.org/10.4143/crt.2016.433
Web of Science 26
Crossref 28
Clinically Significant Unclassified Variants in
BRCA1
and
BRCA2
Genes among Korean Breast Cancer Patients
Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2017;49(3):627-634. Published online September 13, 2016 DOI:
https://doi.org/10.4143/crt.2016.292
Web of Science 12
Crossref 10
Comparison of Clinical Outcomes of
BRCA1/2
Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
Kyung Jin Eoh, Hyung Seok Park, Ji Soo Park, Seung-Tae Lee, Jeongwoo Han, Jung-Yun Lee, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Eun Ji Nam
Cancer Res Treat.
2017;49(2):408-415. Published online July 27, 2016 DOI:
https://doi.org/10.4143/crt.2016.135
Web of Science 28
Crossref 26
Analysis of
BRIP1
Variants among Korean Patients with
BRCA1/2
Mutation-Negative High-Risk Breast Cancer
Haeyoung Kim, Dae-Yeon Cho, Doo Ho Choi, Gee Hue Jung, Inkyung Shin, Won Park, Seung Jae Huh, Seok Jin Nam, Jeong Eon Lee, Won Ho Gil, Seok Won Kim
Cancer Res Treat.
2016;48(3):955-961. Published online January 19, 2016 DOI:
https://doi.org/10.4143/crt.2015.191
Web of Science 8
Crossref 8
Germline Mutation of
BRCA2
Gene in Korean Breast / Ovarian Cancer Families
Yong Jin Won, Jae Hwan Oh, Ji Hyun Kim, Dong Young Noh, Kuk Jin Choe, Soon Beom Kang, Lee Su Kim, Man Su Ro, Nam Sun Paik, Dae Hyun Yang, Se Min Oh, Soon Nam Lee, Kyung Kook Kim, Jae Gahb Park
J Korean Cancer Assoc.
1998;30(2):242-252.
1
Journal Impact Factor 4.1